Insider Transactions in Q2 2024 at Cvs Health Corp (CVS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2024
|
J Scott Kirby Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,912
+34.08%
|
$165,984
$57.52 P/Share
|
|
May 16
2024
|
Michael F Mahoney Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+35.31%
|
$124,488
$57.52 P/Share
|
|
May 16
2024
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,314
+50.0%
|
$131,898
$57.52 P/Share
|
|
May 16
2024
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,314
+1.87%
|
$131,898
$57.52 P/Share
|
|
May 16
2024
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,314
+6.78%
|
$131,898
$57.52 P/Share
|
|
May 16
2024
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,347
+6.37%
|
$133,779
$57.52 P/Share
|
|
May 16
2024
|
Jeffrey R. Balser Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,184
+23.08%
|
$124,488
$57.52 P/Share
|
|
May 02
2024
|
Michael F Mahoney Director |
BUY
Open market or private purchase
|
Direct |
9,181
+49.53%
|
$495,774
$54.49 P/Share
|
|
May 02
2024
|
Edward J Ludwig Director |
BUY
Open market or private purchase
|
Direct |
1,000
+4.42%
|
$53,000
$53.88 P/Share
|
|
Apr 01
2024
|
J. David Joyner President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
28,280
+39.0%
|
-
|
|
Apr 01
2024
|
Laurie P. Havanec EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,426
+50.0%
|
$744,654
$79.56 P/Share
|
|
Apr 01
2024
|
Laurie P. Havanec EVP and Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,630
-16.89%
|
$602,770
$79.56 P/Share
|
|
Apr 01
2024
|
Sreekanth K Chaguturu EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,913
+22.61%
|
$546,127
$79.56 P/Share
|
|
Apr 01
2024
|
Sreekanth K Chaguturu EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,298
-8.88%
|
$181,542
$79.56 P/Share
|
|
Apr 01
2024
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,683
+41.42%
|
$843,957
$79.56 P/Share
|
|
Apr 01
2024
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,004
-14.03%
|
$237,316
$79.56 P/Share
|
|
Apr 01
2024
|
Samrat S. Khichi EVP, CPO and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
12,569
+22.03%
|
-
|
|
Apr 01
2024
|
Brian A Kane EVP/President, Aetna |
BUY
Grant, award, or other acquisition
|
Direct |
12,569
+50.0%
|
-
|
|
Apr 01
2024
|
Tilak Mandadi EVP, Chief DDAT Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,339
+16.46%
|
-
|
|
Apr 01
2024
|
Prem S Shah EVP and Group President |
BUY
Grant, award, or other acquisition
|
Direct |
15,082
+28.93%
|
-
|
|
Apr 01
2024
|
Prem S Shah EVP and Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,892
-8.2%
|
$623,468
$79.56 P/Share
|
|
Apr 01
2024
|
Thomas F. Cowhey EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,082
+23.91%
|
-
|
|
Apr 01
2024
|
Thomas F. Cowhey EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,719
-4.6%
|
$135,801
$79.56 P/Share
|
|
Apr 01
2024
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
61,953
-45.34%
|
$4,894,287
$79.56 P/Share
|
|
Apr 01
2024
|
Karen S Lynch President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,248
+50.0%
|
$3,574,592
$79.56 P/Share
|